Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
801.95
1.55 (0.19%)
BSENSE

Oct 09

BSE+NSE Vol: 1.48 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Marksans Pharma
Caplin Point Lab
Alivus Life
ERIS Lifescience
Pfizer
Astrazeneca Phar
OneSource Speci.
Jubilant Pharmo
Natco Pharma
Cohance Life
Alembic Pharma
Why is Alembic Pharmaceuticals Ltd. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.68%
EBIT Growth (5y)
-6.71%
EBIT to Interest (avg)
11.07
Debt to EBITDA (avg)
1.02
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.03
Tax Ratio
4.98%
Dividend Payout Ratio
37.06%
Pledged Shares
0
Institutional Holding
20.12%
ROCE (avg)
11.33%
ROE (avg)
10.96%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
21
Industry P/E
36
Price to Book Value
2.77
EV to EBIT
20.49
EV to EBITDA
14.49
EV to Capital Employed
2.45
EV to Sales
2.18
PEG Ratio
0.77
Dividend Yield
1.50%
ROCE (Latest)
11.59%
ROE (Latest)
12.93%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
PAT(Latest six months)

At Rs 400.53 cr has Grown at 28.68%

NET SALES(Q)

Highest at Rs 2,149.77 cr

PBDIT(Q)

Highest at Rs 331.86 cr.

-3What is not working for the Company
INTEREST(Q)

Highest at Rs 27.61 cr

Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Profit After Tax (PAT) - Latest six months
At Rs 400.53 cr has Grown at 28.68%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 2,149.77 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 2,149.77 cr has Grown at 25.66%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 331.86 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Here's what is not working for Alembic Pharma
Interest - Quarterly
Highest at Rs 27.61 cr
in the last five quarters and Increased by 22.38 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."